Hiller 2004.
Methods | Randomized, double‐blind, active‐controlled Medications administered immediately after induction of anesthesia (surgeries averaged around 30 min) |
|
Participants | Type of surgery: elective tonsillectomy Propacetamol group Entered/completing: 26/25 Age (mean, SD): 29 ± 11 Sex (male, %): 52 Diclofenac group Entered/completing: 25/25 Age (mean, SD): 27 ± 7 Sex (male, %): 44 |
|
Interventions | Intervention: 2 g propacetamol in 100 ml normal saline Control: 75 mg diclofenac Control: 2 g propacetamol plus 75 mg diclofenac (not included in our analysis) |
|
Outcomes | Opioid consumption (oxycodone) Pain intensity at rest and on swallowing (VRS, VAS) Patient satisfaction (VAS) |
|
Source of funding | Not reported | |
Were treatment groups comparable at baseline? | Yes: demographics; duration of surgery, intraoperative opioid use; blood loss | |
Details of preoperative pain | Not reported | |
Notes | — | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not described |
Allocation concealment (selection bias) | Low risk | Sealed envelope method |
Blinding (performance bias and detection bias) All outcomes | Low risk | Nurse preparing solutions did not participate in the study. To maintain double‐blind design volumes infused were equal. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Various reasons for dropouts amongst groups, data analyzed in completers only, but minimal missing data |
Selective reporting (reporting bias) | Unclear risk | Outcomes not specified in Methods section; possibility of additional post‐hoc analyses cannot be ruled out |
Size | High risk | Fewer than 50 participants per arm of the study (26 propacetamol, 25 diclofenac) |